🇺🇸 IXIARO in United States

25 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Vomiting — 4 reports (16%)
  2. Drug Interaction — 3 reports (12%)
  3. Nausea — 3 reports (12%)
  4. Renal Failure Acute — 3 reports (12%)
  5. Urticaria — 3 reports (12%)
  6. Urticaria Chronic — 3 reports (12%)
  7. Decreased Appetite — 2 reports (8%)
  8. Diarrhoea — 2 reports (8%)
  9. Abdominal Pain Lower — 1 report (4%)
  10. Anuria — 1 report (4%)

Source database →

IXIARO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is IXIARO approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for IXIARO in United States?

SK Bioscience Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.